The growing concern to maintain pharmacological efficacy and product quality, to ensure patient’s safety, has led to a greater focus on the need for aseptic fill / finish; drug developers prefer to outsource these operations to benefit from the expertise of service providers

Roots Analysis is pleased to announce the publication of its recent study, titled, “Aseptic Fill Finish Market, 2023-2035”

The report features an extensive study of the current market landscape and future opportunities for companies with capabilities in aseptic fill / finish services market manufacturing. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:

• A  summary of the key insights derived from our research, which offers a high-level view on the likely evolution of the aseptic fill finish service providers market in the short to mid-term, and long term.
• A general introduction to pharmaceuticals and contract manufacturing, which features a detailed discussion on the need for outsourcing within the pharmaceutical industry and key operations outsourced by biologic and small molecule drug developers, including fill finish. It also provides information on the key considerations for selecting a fill finish service provider, along with the advantages and risks posed by outsourcing fill finish operations.
• A detailed assessment of the overall landscape of aseptic fill finish service providers, along with information on several relevant parameters.
• A review of the overall landscape of companies offering aseptic fill finish services for biologics, along with analyses on a number of relevant parameters.
• A detailed assessment of the overall market landscape of the companies offering aseptic fill finish services for small molecules, along with analyses on a number of relevant parameters.
• Tabulated profiles of key players based in North America, Europe and Asia-Pacific.
• A detailed analysis of the various partnerships and collaborations established by stakeholders in this domain, since 2013.
• A case study focused on use of robotic systems in fill finish operations.
• A case study on use of ready-to-use packaging components in aseptic fill finish operations.
• A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)

• Type of Molecule
• Small molecules
• Biologics

• Type of Packaging Container
• Ampoules
• Cartridges
• Syringes
• Vials

• Type of Drug Product
• Antibodies
• Cell Therapies
• Gene Therapies
• Oligonucleotides
• Recombinant Proteins
• Vaccines
• Other Drug Products

• Target Therapeutic Area
• Autoimmune disorders
• Oncological Disorders
• Cardiovascular Disorders
• Infectious Diseases
• Other Disorders

• Scale Of Operation
• Preclinical / Clinical
• Commercial

• Company Size
• Large
• Mid-sized
• Small

• Key Geographical Regions
• North America
• Europe
• Asia-Pacific
• Middle East and North Africa

• Latin America

Key companies covered in the report

• BD Biosciences
• AbbVie Contract Manufacturing
• Aenova
• APL
• Asymchem
• BD Biosciences
• BioPharma Solutions
• BioReliance
• Boehringer Ingelheim BioXcellence
• Catalent Biologics
• Charles River Laboratories
• CordenPharma
• Delpharm
• Fareva
• Fresenius Kabi
• GlaxoSmithKline
• Hetero Drugs
• Intas Pharmaceuticals
• Lonza
• Patheon
• Pfizer CentreOne
• Pierre Fabre
• PiSA Farmaceutica
• Plastikon Healthcare
• Recipharm
• Samsung Biologics
• Sharp Services
• Siegfried
• Syngene
• Takara Bio
• Wacker Biotech
• Wockhardt
• WuXi Biologics

To view more details on this report, click on the link

https://www.rootsanalysis.com/reports/aseptic-fill-finish-market.html

You may also be interested in the following titles:

Bispecific Antibodies Market

Antiviral Drugs: The Unmet Requirement in the Pharmaceutical Space

Digital Biomanufacturing Market

Roots Analysis Consulting - the preferred research partner for global firms

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

[email protected]